These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 25939302)
1. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease. Brinton EA Cardiol Clin; 2015 May; 33(2):309-23. PubMed ID: 25939302 [TBL] [Abstract][Full Text] [Related]
2. Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease. Brinton EA Endocrinol Metab Clin North Am; 2016 Mar; 45(1):185-204. PubMed ID: 26893005 [TBL] [Abstract][Full Text] [Related]
3. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014. Fan W; Philip S; Granowitz C; Toth PP; Wong ND Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639 [TBL] [Abstract][Full Text] [Related]
4. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Nordestgaard BG Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957 [TBL] [Abstract][Full Text] [Related]
5. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
6. Is hypertriglyceridemia atherogenic? Roubille F; Sultan A; Huet F; Leclercq F; Macia JC; Gervasoni R; Delseny D; Akodad M; Roubille C Presse Med; 2018 Sep; 47(9):757-763. PubMed ID: 30262206 [TBL] [Abstract][Full Text] [Related]
12. [Statin therapy for atherogenic hypertriglyceridemia]. Koba S Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertriglyceridemia: a review of current options. Vrablík M; Češka R Physiol Res; 2015; 64(Suppl 3):S331-40. PubMed ID: 26680666 [TBL] [Abstract][Full Text] [Related]
14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
15. What is really new in triglyceride guidelines? Hussain A; Al Rifai M; Hermel M; Slipczuk L; Virani SS Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):73-80. PubMed ID: 36722448 [TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia and atherosclerosis. Peng J; Luo F; Ruan G; Peng R; Li X Lipids Health Dis; 2017 Dec; 16(1):233. PubMed ID: 29212549 [TBL] [Abstract][Full Text] [Related]
17. Role of fibrates in the management of hypertriglyceridemia. Rader DJ; Haffner SM Am J Cardiol; 1999 May; 83(9B):30F-35F. PubMed ID: 10357573 [TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia: the importance of identifying patients at risk. Kushner PA; Cobble ME Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158 [TBL] [Abstract][Full Text] [Related]
19. Challenges in the treatment of hypertriglyceridemia: glass half empty or half full? Sahebkar A; Watts GF Expert Rev Clin Pharmacol; 2015; 8(4):363-6. PubMed ID: 26044648 [TBL] [Abstract][Full Text] [Related]
20. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]